Ekot (with Audio), Kina godkänner Sinopharms vaccin

Kina godkänner Sinopharms vaccin

2020-12-31 07:45:00

I Kina har nu den statliga tillverkaren Sinopharms covid19-vaccin godkänts. Det är det första av en rad kinesiska vaccin som godkänns för en bredare allmänhet.

Det har inte presenterats några detaljerade uppgifter om vaccinet, men en representant för företaget har uppgett att man nått nästan 80 procents effektivitet i tester.

Enligt uppgift har redan mer än 4 miljoner kineser vaccinerats mot covid-19, men det har skett med vaccin där de kliniska prövningarna ännu inte är avslutade.

Try LingQ and learn from Netflix shows, Youtube videos, news articles and more.

@import url(https://fonts.googleapis.com/css2?family=Rubik:wght@700&display=swap);body.is-unscrollable{overflow-y:hidden}body .lqp{position:relative;font-family:Rubik,BlinkMacSystemFont,-apple-system,"Segoe UI",Roboto,Oxygen,Ubuntu,Cantarell,"Fira Sans","Droid Sans","Helvetica Neue",Helvetica,Arial,sans-serif!important;font-weight:700;-webkit-box-sizing:border-box;box-sizing:border-box;color:#fff;overflow:hidden;width:520px;max-width:calc(100vw - 32px);background-color:#091a2f;-webkit-transition:-webkit-transform .34s cubic-bezier(1,-.2,.6,1);transition:-webkit-transform .34s cubic-bezier(1,-.2,.6,1);transition:transform .34s cubic-bezier(1,-.2,.6,1);transition:transform .34s cubic-bezier(1,-.2,.6,1),-webkit-transform .34s cubic-bezier(1,-.2,.6,1);-webkit-transform:translateY(-112vh);-ms-transform:translateY(-112vh);transform:translateY(-112vh);padding:32px 16px 0;margin:10vh 16px}body .lqp *{margin:0;padding:0;border:none;outline:0;line-height:1.2em}body .lqp-wrap{z-index:9999999999;visibility:hidden;position:fixed;display:-webkit-box!important;display:-ms-flexbox!important;display:flex!important;-webkit-box-orient:vertical;-webkit-box-direction:normal;-ms-flex-direction:column;flex-direction:column;-webkit-box-align:center;-ms-flex-align:center;align-items:center;overflow-x:hidden;overflow-y:auto;top:0;left:0;right:0;bottom:0;-webkit-transition:opacity .5s ease-out,visibility 0s .5s;transition:opacity .5s ease-out,visibility 0s .5s}body .lqp-wrap:not(.is-open) .lqp-app-screen{-webkit-transform:translateY(100%);-ms-transform:translateY(100%);transform:translateY(100%)}body .lqp-wrap.is-open{visibility:visible!important;opacity:1!important;-webkit-transition:opacity .5s ease-out,visibility 0s 0s;transition:opacity .5s ease-out,visibility 0s 0s}body .lqp-wrap.is-open .lqp{-webkit-transform:translate(0);-ms-transform:translate(0);transform:translate(0);-webkit-transition:-webkit-transform .5s cubic-bezier(0,0,0,1.1);transition:-webkit-transform .5s cubic-bezier(0,0,0,1.1);transition:transform .5s cubic-bezier(0,0,0,1.1);transition:transform .5s cubic-bezier(0,0,0,1.1),-webkit-transform .5s cubic-bezier(0,0,0,1.1)}body .lqp-wrap.is-open .lqp-bg{opacity:.78}body .lqp-close{position:absolute;display:-webkit-box;display:-ms-flexbox;display:flex;z-index:5;cursor:pointer;top:0;right:0;padding:12px;border-radius:50%;background-color:transparent;opacity:.6}body .lqp-body{display:grid}body .lqp-content{padding-bottom:32px}body .lqp-offer-1{font-size:26px;margin-bottom:4px;margin-bottom:4px}body .lqp-offer-2{font-size:36px;color:#478ef7}body .lqp-offer-3{font-size:36px}body .lqp-title{margin-bottom:24px}body .lqp-bg{position:fixed;z-index:-2;background-color:#000;opacity:0;top:0;left:0;right:0;bottom:-30vh;-webkit-transition:.32s ease-out;transition:.32s ease-out}body .lqp-anim-text{position:relative;display:inline-block;color:#fbb718!important;vertical-align:text-top;overflow:hidden;height:1em;vertical-align:text-top}body .lqp-cta{font-size:18px;display:inline-grid;-webkit-box-pack:center;-ms-flex-pack:center;justify-content:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;min-height:48px;min-width:243px;color:#091a2f;background-color:#fbb718;border:1px solid #fbb718;border-radius:80px;text-decoration:none;margin-top:24px;-webkit-transition:color .1s ease-out,background-color .1s ease-out;transition:color .1s ease-out,background-color .1s ease-out}body .lqp-anim-list{display:block!important;-webkit-transition:-webkit-transform .3s ease-in-out;transition:-webkit-transform .3s ease-in-out;transition:transform .3s ease-in-out;transition:transform .3s ease-in-out,-webkit-transform .3s ease-in-out}body .lqp-anim-item{margin:0!important;padding:0!important}body .lqp-bg-imgs svg{position:absolute;z-index:-1;bottom:0;right:0}body .lqp-app-screen{-webkit-transform:translateY(0);-ms-transform:translateY(0);transform:translateY(0);-webkit-transition:-webkit-transform .38s 40ms ease-out;transition:-webkit-transform .38s 40ms ease-out;transition:transform .38s 40ms ease-out;transition:transform .38s 40ms ease-out,-webkit-transform .38s 40ms ease-out;background-position:top center;background-size:100% auto;background-repeat:no-repeat;margin:0 auto}body .lqp-app-screen img{max-width:100%!important;vertical-align:middle}html body.is-unscrollable{overflow-y:hidden!important}@media only screen and (min-width:769px){body .lqp{width:946px;padding:46px 32px 0;margin:20vh 16px}body .lqp-body{grid-template-columns:auto auto;grid-gap:32px}body .lqp-content{padding-bottom:68px}body .lqp-offer-1{font-size:33px}body .lqp-offer-2{font-size:44px}body .lqp-offer-3{font-size:42px}body .lqp-app-screen{display:block;position:relative;width:302px;height:100%}}@media only screen and (min-width:932px){body .lqp{padding:54px 68px 0;margin:18vh 16px}body .lqp-close{padding:24px;-webkit-transition:-webkit-transform .2s ease;transition:-webkit-transform .2s ease;transition:transform .2s ease;transition:transform .2s ease,-webkit-transform .2s ease}body .lqp-close:hover{-webkit-transform:rotate(90deg);-ms-transform:rotate(90deg);transform:rotate(90deg);opacity:1}body .lqp-offer-1{font-size:36px}body .lqp-offer-3{font-size:52px}body .lqp-cta:hover{background-color:#091a2f;color:#fff}}@media only screen and (max-width:768px){body .lqp-content{text-align:center;padding-bottom:42px}body .lqp-bg-imgs svg{width:100%;height:auto}body .lqp-app-screen{width:254px;height:263px}}@media only screen and (max-width:768px) and (max-width:768px){body .lqp-bg-imgs svg#bg-radial{width:auto;height:72%;max-height:492px}}@media only screen and (max-width:371px){body .lqp-offer-1{font-size:24px}body .lqp-offer-2{font-size:32px}body .lqp-offer-3{font-size:32px}}

Ekot (with Audio), Kina godkänner Sinopharms vaccin

Want to learn Švedų? Start now!

Want to learn Švedų?
Start now!